Shenzhen Lifotronic Technology Co., Ltd. Stock: price and insider trades · China
普门科技
No insider purchase over the last 90 days. The latest, by 刘先成, was filed 20 Jul 2026.
Shenzhen Lifotronic Technology Co., Ltd.: what insiders have been doing
Every trade that managers of Shenzhen Lifotronic Technology Co., Ltd. disclose to SSE / SZSE (CSRC) is tracked on this page. The company sits in the Health Care sector. Over the twelve months to 6 November 2026, 2 filings were filed, from 2 insiders.
Open-market activity splits into 1 purchase totalling €31k and 1 sale totalling €86k; 1 insider sit on the buying side and 1 insider on the selling side. Taken together, the sales exceed the purchases by €55k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The buyers include 1 board member. The largest single trade was a sale of €86k by 邱亮, published on 1 September 2026.
For context, the typical company on the same exchange (median of 514 companies) published 2 filings over the same period, against 2 filings here. The full history, which starts in 2023, counts 2 purchases against 6 sales.
The last purchase on record was published on 20 July 2026, which is 111 days ago.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleSince the insiders bought
- +7.5%Entry CN¥10.75 · Close 04 Nov 2026 CN¥11.56
- -29.6%Entry CN¥18.84 · Close at T+365 CN¥13.26
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Shenzhen Lifotronic Technology Co., Ltd. Strong Buy (bullish), based on 2 analysts. Average price target: CN¥14.55.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 60,000 shares@ CN¥87.3211100.0% of flowA股XSHGSSE:273000001429350180
- 22,508 shares@ CN¥83.362100.0% of flowA股XSHGSSE:273000000845675260Canonical exit: 18 Oct 2026 (T+90)
- 21,943 shares37.2% of flowA股XSHGSSE:173000006966373400
- 200 shares1.2% of flowA股XSHGSSE:173000006897808030Canonical exit: 3 Dec 2023 (T+90)
- 8,057 shares13.1% of flowA股XSHGSSE:173000006887283940
- 21,000 shares43.7% of flowA股XSHGSSE:173000006306370660
- 3,000 shares6.1% of flowA股XSHGSSE:173000006299387680
- 12,000 shares98.8% of flowA股XSHGSSE:173000006296783420
8 of 8 declarations
About Shenzhen Lifotronic Technology Co., Ltd.
普门科技 is a company in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and commercialization of innovative medical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
